Many patients with type 2 diabetes who achieve inadequate glycaemic control on metformin monotherapy will have a GLP-1 receptor agonist like Rybelsus added to their treatment regimen, in accordance with NICE guidance (NG28)
Comprehensive Health Benefits Beyond the Scale Because obesity is a complex metabolic condition, balancing your system with a tailored GLP-1 protocol protects your long-term health from head to toe: Protects Your Heart: Clinical studies show a significant reduction in the risk of heart attacks, strokes, and cardiovascular strain
However, as with all combined treatments, this should only be done under the guidance of a qualified healthcare professional
For those who havent seen results with metformin or lifestyle interventions, tirzepatide provides a promising alternative that addresses multiple aspects of PCOS simultaneously
$199/mo injection Compounded semaglutide (injection) $199 first dose, then $299 Compounded semaglutide (oral lozenges) $199 first dose, then $299 Compounded semaglutide (oral drops) $299 first dose, then $326 Compounded semaglutide (oral liposomal tablets) $299 (all doses) Compounded semaglutide (microdose) $149 (all doses) Compounded tirzepatide (injection) $299 first dose, then $399 Compounded tirzepatide (microdose) $199 (all doses) Wegovy (pen) From $149 (promotional through April 2026), then $199$349 Zepbound (vials) $299 first dose, $399 second, $499 third dose (regular price $599$1,049 at higher doses) INCLUDES Initial Lab Test Not included Not included, not required Monthly Membership Fee None None for compounded